Trial Profile
Randomized Phase II-III Trial of Post-operative Treatment of Pancreatic Adenocarcinoma: Gemcitabine Versus PEFG Followed by Radiochemotherapy With Concomitant Continuous Infusion of 5-fluorouracil.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 21 Sep 2012
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Capecitabine; Cisplatin; Epirubicin; Fluorouracil
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- Acronyms PACT-7
- 12 Jan 2012 Trial acronym (PACT-7) identified as reported by ClinicalTrials.gov.
- 20 Sep 2009 Results presented at the 15th European Cancer Conference and the 34th Congress of the European Society for Medical Oncology (ECCO/ESMO 2009).
- 20 Sep 2009 Status changed from recruiting to completed.